more_reports

Streetwise Medical Devices Articles



Inari Shares Flow 14% Higher on Triple Digit YoY Growth in Procedures and Revenues
Source: Streetwise Reports  (1/13/21)
Shares of Inari Medical Inc. established a new 52-week high after the company reported that preliminary revenue in Q4/20 increased year-over-year by greater than 140%. More >


Biotech Collaborates to Advance Psychedelics Use in Cancer, Other Applications
Source: Streetwise Reports  (11/23/20)
Revive Therapeutics enters an agreement with PharmaTher, a specialty psychedelics pharmaceutical firm. More >


Glaukos Shares Pressured Higher After Firm Reports 11% Rise in Q3 Revenue
Source: Streetwise Reports  (11/6/20)
Shares of Glaukos Corp. traded 9% higher after the company reported Q3/20 financial results that included an 11% YoY increase in glaucoma and corneal health net sales. More >


Inspire Medical's Shareholders Rest Comfortably on Q3 Earnings and Raised FY Outlook
Source: Streetwise Reports  (11/3/20)
Shares of Inspire Medical Systems traded 30% higher and set a new 52-week high after the company reported Q3/20 financial results that included a 72% rise in YoY revenue. More >


Align Technology Shares Head Straight Up on 20.9% Q3 Revenue Growth as Firm Celebrates its 9 Millionth Invisalign Patient
Source: Streetwise Reports  (10/22/20)
Shares of Align Technology traded 35% higher and climbed to a new 52-week high after the company reported Q3/20 financial results that included a 20.9% YoY increase in net revenues. More >


U.S. Medical Device Firm to Acquire Developer of Dissection Stent
Source: Streetwise Reports  (9/9/20)
The specifics of the deal and the next steps for CryoLife are presented in a Ladenburg Thalmann report. More >


AI Tech Firm Provides COVID-19 Contact Tracing Solution Update
Source: Streetwise Reports  (7/20/20)
Loop Insights continues to educate governments and venue operators around the world about its easily implemented platform. More >


Analyst: Integrated Model Positioned to Monetize on Telehealth Emergence
Source: Streetwise Reports  (7/13/20)
Echelon Capital Markets initiates coverage and explains why it is bullish on CloudMD Software & Services. More >


Surgical Equipment Firm Delivers Innovative Imaging Systems to Leading Urologists
Source: Streetwise Reports  (5/27/20)
Imagin Medical delivered two functional i/Blueâ„¢ Imaging Systems for use in conducting in vivo studies and virtual demonstrations for evaluation by leading urologists. More >


SmileDirectClub Awarded US Patent for SmileShop Concept and Plans to Reopen Stores in May
Source: Streetwise Reports  (4/28/20)
SmileDirectClub shares traded 20% higher after the company reported it has been awarded a U.S. patent for its SmileShop retail concept and treatment process and that it plans to reopen stores on a rolling basis starting in May. More >


West Pharma Services' Shares Rise 10% on Q1 Sales Growth and Raised FY Earnings Guidance
Source: Streetwise Reports  (4/23/20)
Shares of West Pharmaceutical Services traded higher and established a new 52-week high price after the firm reported Q1/20 earnings that included a 10.8% increase in YoY revenues. More >


CytoSorbents Shares Trade 20% Higher as FDA Grants CytoSorb EUA for COVID-19
Source: Streetwise Reports  (4/13/20)
Shares of CytoSorbents traded higher setting a new 52-week intraday high price after the company reported that the FDA granted emergency use authorization for CytoSorb for use in patients with COVID-19. More >


Inhaled Nitric Oxide Being Tested as COVID-19 Treatment
Source: Streetwise Reports  (3/26/20)
Nu-Med Plus has two collaborative, Phase 2 clinical trials in progress, which it is diligently monitoring. More >


Nemaura Medical Accelerates Launch of sugarBEAT Wearable Continuous Glucose Monitor
Source: Streetwise Reports  (2/26/20)
Shares of Nemaura Medical traded 20% higher after the firm reported that it is investigating using its non-invasive continuous glucose monitor sugarBEAT® jointly with its planned health subscription service BEAT®diabetes, to provide personalized lifestyle coaching for people with Type 2 diabetes and prediabetes. More >


Accuray Shares Rise on Q2 Earnings, Increased Backlog and Raised FY/20 EBITDA Guidance
Source: Streetwise Reports  (1/29/20)
Shares of Accuray traded 15% higher today after the company reported Q2/20 financial results. More >


Imaging System Developer Outlines Plan for 2020
Source: Streetwise Reports  (1/24/20)
The company continues to advance its device toward commercialization. More >


Two Analysts See Company as a Buy for 'Game-Changing' Potential in Bladder Cancer Detection and Surgery
Source: Streetwise Reports  (1/14/20)
The disruptive technology is 'poised to deliver significant advancement in bladder cancer detection.' More >


Transenterix Shares Trade Up 25% on FDA Filing for First Machine Vision System in Robotic Surgery
Source: Streetwise Reports  (1/14/20)
Shares of Transenterix opened 50% higher after the company reported that it has submitted a 510(k) submission to the FDA for the first machine vision system for use in robotic surgery. More >


Developer Completes Design Verification of Imaging Device for Bladder Cancer
Source: Streetwise Reports  (1/10/20)
In doing so, it gets one step closer to market approval from U.S. regulators. More >


Neovasc Shares Climb 80% Upon FDA Premarket Approval Filing for Refractory Angina Device
Source: Streetwise Reports  (12/31/19)
Shares of specialty cardiovascular medical device company Neovasc Inc. opened more than 100% higher after the firm reported that it submitted a Premarket Approval application to the FDA for its Neovasc Reducer device for use in the treatment of refractory angina. More >


Biotech Advances Imaging Product to Functional Development Phase
Source: Streetwise Reports  (12/27/19)
The company aims to conduct pilot production testing in Q1/20. More >


Microbot Shares Soar on Claims It Has Created the World's First Fully Disposable Endovascular Robotic System
Source: Streetwise Reports  (12/24/19)
Shares of Microbot Medical traded 70% higher after the company reported that in January 2020 it will unveil the world's first fully disposable robotic system for endovascular procedures. The firm claims that its breakthrough technology features compact design, remote operation capabilities and an integrated "One & Done" tool to democratize endovascular procedures. More >


Regenerative Medicine Firm Advances Multifaceted Pipeline
Source: Streetwise Reports  (11/26/19)
The company continues advancing its cell therapies and medical device. More >


Reliq Re-establishes Itself as Community Care Technology Leader Amidst Sweeping Federal Medicare/Medicaid Changes
Source: Knox Henderson for Streetwise Reports  (11/13/19)
A shift in the industry leads to big new contracts and parabolic stock performance for this small cap. More >


Electromed Earnings Spark a 25% Increase in Its Share Price
Source: Streetwise Reports  (11/13/19)
Shares of SmartVest maker Electromed traded 25% higher today after the firm reported Q1/20 earnings. The firm's shares set a 52-week high price after reporting a 14.1% increase in year-over-year quarterly revenue and a six-fold increase in net income per share. More >


Showing Results: 101 to 125 of 330 Prev Next

Notable Quotes

"SMN's drill program could deliver some high-grade hits to the market."
– Brien Lundin, Gold Newsletter (Jefferson Financial)
"EMO filed an appeal of the resolution dated May 30."
– Robert Sinn, Goldfinger Capital
"DRY just hit the same structure that returned 301.67 g/t in May."
– Chen Lin, What Is Chen Buying? What Is Chen Selling?
"We are increasing our price target on MAG."
– Joe Reagor, ROTH Capital Partners

Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe

More Experts

"MMG is a patience trade as La Plata could be a big prize."
– Peter Krauth, Silver Stock Investor
"WEX released an excellent new resource report."
– Chen Lin, What Is Chen Buying? What Is Chen Selling?
"We are upgrading our valuation on SM."
– Oliver O'Donnell, VSA Capital
"Things are starting to happen for IRV in Japan."
– Jay Taylor, Gold, Energy & Tech Stocks